Reference : Tolvaptan in autosomal dominant polycystic kidney disease.
Scientific journals : Letter to the editor
Human health sciences : Urology & nephrology
http://hdl.handle.net/2268/147052
Tolvaptan in autosomal dominant polycystic kidney disease.
English
JOURET, François mailto [Centre Hospitalier Universitaire de Liège - CHU > > Néphrologie >]
Krzesinski, Jean-Marie mailto [Université de Liège - ULiège > Département des sciences cliniques > Néphrologie >]
2013
New England Journal of Medicine
368
13
1258-9
Yes (verified by ORBi)
International
0028-4793
1533-4406
United States
[en] Benzazepines/therapeutic use ; Female ; Humans ; Kidney/pathology ; Male ; Polycystic Kidney, Autosomal Dominant/drug therapy ; Receptors, Vasopressin/antagonists & inhibitors
http://hdl.handle.net/2268/147052
10.1056/NEJMc1300762

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
nejmc1300762.pdfPublisher postprint306.23 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.